Financial Advocates Investment Management’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,268
Closed -$201K 706
2023
Q1
$201K Sell
1,268
-587
-32% -$88K 0.01% 688
2022
Q4
$260K Buy
+1,855
New +$263K 0.02% 597
2022
Q2
Sell
-2,084
Closed -$290K 705
2022
Q1
$290K Buy
2,084
+411
+25% +$63K 0.02% 589
2021
Q4
$292K Sell
1,673
-214
-11% -$35.7K 0.02% 641
2021
Q3
$312K Buy
+1,887
New +$325K 0.02% 608
2021
Q2
Sell
-1,621
Closed -$312K 752
2021
Q1
$312K Sell
1,621
-31
-2% -$5.97K 0.02% 594
2020
Q4
$334K Buy
1,652
+459
+38% +$95K 0.02% 539
2020
Q3
$251K Buy
1,193
+63
+6% +$14K 0.02% 520
2020
Q2
$248K Buy
+1,130
New +$226K 0.02% 507
2019
Q2
Sell
-1,712
Closed -$275K 470
2019
Q1
$275K Buy
1,712
+54
+3% +$8.38K 0.03% 377
2018
Q4
$256K Buy
1,658
+55
+3% +$8.57K 0.03% 372
2018
Q3
$241K Sell
1,603
-154
-9% -$21.9K 0.03% 441
2018
Q2
$234K Sell
1,757
-589
-25% -$72.7K 0.03% 430
2018
Q1
$312K Buy
2,346
+593
+34% +$79.6K 0.04% 359
2017
Q4
$260K Buy
+1,753
New +$239K 0.04% 389

Other funds holding CLX

Financial Advocates Investment Management's CLX Position: Q2 2023 in Review

Financial Advocates Investment Management sold out of Clorox (CLX) in Q2 2023, closing a stake of 1,268 shares — an estimated $201K sold.

Financial Advocates Investment Management first reported a position in CLX in Q4 2017 and held it in 15 quarters. The position peaked at $334K in Q4 2020. 1,144 funds tracked by Wall St. Rank hold CLX as of Q2 2023.

  • Financial Advocates Investment Management reported no remaining Clorox position as of Q2 2023 after selling out during the quarter.
  • Financial Advocates Investment Management sold 1,268 Clorox shares in Q2 2023, an estimated $201K.
  • Financial Advocates Investment Management first reported a position in Clorox in Q4 2017 and held it in 15 quarters.
  • Financial Advocates Investment Management's Clorox position peaked at $334K in Q4 2020.
  • 1,144 funds tracked by Wall St. Rank held Clorox as of Q2 2023.

Based on Financial Advocates Investment Management's 13F filing for Q2 2023, filed 7 Aug 2023.